Literature DB >> 19712648

Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.

M G Baker1, N Wilson, Q S Huang, S Paine, L Lopez, D Bandaranayake, M Tobias, K Mason, G F Mackereth, M Jacobs, C Thornley, S Roberts, C McArthur.   

Abstract

Following the detection of imported cases of pandemic influenza A(H1N1)v on 25 April 2009, New Zealand implemented containment measures that appeared to slow establishment of the pandemic during May. The pandemic accelerated markedly in June, reaching a peak within four to six weeks, and has been declining since mid-July. By 23 August there had been 3,179 recorded cases (97.8% reported as confirmed), including 972 hospitalisations, 114 intensive care admissions, and 16 deaths. Influenza-like illness (ILI) surveillance in general practice suggests that 7.5% (95% CI: 3.4-11.2) of the population of New Zealand had symptomatic infection, giving a case fatality ratio of 0.005%. Hospitalisations were markedly higher for Māori (age standardised relative risk (RR)=3.0, 95% CI: 2.9-3.2) and Pacific peoples (RR=6.7, 95% CI: 6.2-7.1) compared with Europeans and others. The apparent decline of the pandemic (shown by all surveillance systems) cannot be fully explained. New Zealand remains in the middle of its traditional influenza season, the influenza A(H1N1)v virus appears relatively infectious, and we estimate that only about 11% of the population have been infected by this novel agent.

Entities:  

Mesh:

Year:  2009        PMID: 19712648     DOI: 10.2807/ese.14.34.19319-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  91 in total

Review 1.  Methods for molecular surveillance of influenza.

Authors:  Ruixue Wang; Jeffery K Taubenberger
Journal:  Expert Rev Anti Infect Ther       Date:  2010-05       Impact factor: 5.091

2.  Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.

Authors:  Danuta M Skowronski; Travis S Hottes; Naveed Z Janjua; Dale Purych; Suzana Sabaiduc; Tracy Chan; Gaston De Serres; Jennifer Gardy; Janet E McElhaney; David M Patrick; Martin Petric
Journal:  CMAJ       Date:  2010-10-18       Impact factor: 8.262

3.  Potential intensive care unit ventilator demand/capacity mismatch due to novel swine-origin H1N1 in Canada.

Authors:  Paul Smetanin; David Stiff; Anand Kumar; Paul Kobak; Ryan Zarychanski; Neil Simonsen; Frank Plummer
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  VirSim - a model to support pandemic policy making.

Authors:  Tobias Fasth; Marcus Ihlar; Lisa Brouwers
Journal:  PLoS Curr       Date:  2010-09-22

6.  Epidemiological characteristics of the influenza A(H1N1) 2009 pandemic in the Western Pacific Region.

Authors:  Lisa McCallum; Jeffrey Partridge
Journal:  Western Pac Surveill Response J       Date:  2010-12-10

Review 7.  Impact of H1N1 on socially disadvantaged populations: summary of a systematic review.

Authors:  Andrea C Tricco; Erin Lillie; Charlene Soobiah; Laure Perrier; Sharon E Straus
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

8.  Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010).

Authors:  María Morales-Suárez-Varela; Fernando González-Candelas; Jenaro Astray; Jordi Alonso; Ady Castro; Rafael Cantón; Juan Carlos Galán; Olatz Garin; Núria Soldevila; Maretva Baricot; Jesús Castilla; Pere Godoy; Miguel Delgado-Rodríguez; Vicente Martín; José María Mayoral; Tomás Pumarola; José Maria Quintana; Sonia Tamames; Agustín Llopis-González; Angela Domínguez
Journal:  Matern Child Health J       Date:  2014-08

Review 9.  Case fatality risk of influenza A (H1N1pdm09): a systematic review.

Authors:  Jessica Y Wong; Heath Kelly; Dennis K M Ip; Joseph T Wu; Gabriel M Leung; Benjamin J Cowling
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

10.  Early clinical experiences with the new influenza A (H1N1/09).

Authors:  Ralf Winzer; Nicolas Kanig; Sophie Schneitler; Stefan Reuter; Björn Jensen; Irmela Müller-Stöver; Jun Oh; Ortwin Adams; Ertan Mayatepek; Hartmut Hengel; Heiko Schneitler; Dieter Häussinger
Journal:  Dtsch Arztebl Int       Date:  2009-11-20       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.